<DOC>
	<DOCNO>NCT00451490</DOCNO>
	<brief_summary>Phase advance HRV anticipate agomelatine group . It anticipate agomelatine floxentine increase HRV end treatment .</brief_summary>
	<brief_title>The Effect Agomelatine Fluoxentine Heart Rate Variability Patients With Major Depressive Disorder</brief_title>
	<detailed_description>Phase advance HRV anticipate agomelatine group . It anticipate agomelatine floxentine equal efficacy improvement depressive symptom increasement HRV end treatment .</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder , Major</mesh_term>
	<mesh_term>S 20098</mesh_term>
	<criteria>Asian patient Male female 18 65 year outpatient DSMIVTR criterion Major Depressive Disorder Patients cardiac condition physical condition contraindicate drug study Shift worker Patients known nonresponders fluoxetine treatment Pregnancy , breastfeed</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>January 2007</verification_date>
	<keyword>agomelatin</keyword>
	<keyword>prozac</keyword>
	<keyword>heart rate variability</keyword>
	<keyword>major depression</keyword>
	<keyword>sleep</keyword>
	<keyword>depressive symptom</keyword>
</DOC>